Last updated: January 30, 2024
Sponsor: Kansas City Heart Rhythm Research Foundation
Overall Status: Active - Recruiting
Phase
N/A
Condition
Chest Pain
Dermatomyositis (Connective Tissue Disease)
Treatment
Monitoring of patients presenting with PVCs
Clinical Study ID
NCT06060548
KCHRF-ILR_PVC-0011
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Patients > 18 years of age
- Have a Medtronic LINQ II ILR
- Willing and able to give written informed consent
Exclusion
Exclusion Criteria:
- History of myocardial infarction
- Significant flow-limiting coronary artery disease (≥50% stenosis) on invasive coronaryangiography or Computed tomography angiography (CTA).
- History of cardiac arrest
- With existing implantable defibrillators
- Currently pregnant
Study Design
Total Participants: 50
Treatment Group(s): 1
Primary Treatment: Monitoring of patients presenting with PVCs
Phase:
Study Start date:
April 20, 2022
Estimated Completion Date:
March 31, 2025
Study Description
Connect with a study center
Kansas City Heart Rhythm Institute - Roe Clinic
Overland Park, Kansas 66211
United StatesActive - Recruiting
Overland Park Regional Medical Center
Overland Park, Kansas 66215
United StatesActive - Recruiting
Centerpoint Medical Center
Independence, Missouri 64057
United StatesActive - Recruiting
Centerpoint Medical Center Clinic
Independence, Missouri 64057
United StatesActive - Recruiting
Research Medical Center
Kansas City, Missouri 64032
United StatesActive - Recruiting
Research Medical Center Clinic
Kansas City, Missouri 64032
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.